DK3194407T3 - Makrocykliske RIP2-kinaseinhibitorer - Google Patents

Makrocykliske RIP2-kinaseinhibitorer Download PDF

Info

Publication number
DK3194407T3
DK3194407T3 DK15766800.5T DK15766800T DK3194407T3 DK 3194407 T3 DK3194407 T3 DK 3194407T3 DK 15766800 T DK15766800 T DK 15766800T DK 3194407 T3 DK3194407 T3 DK 3194407T3
Authority
DK
Denmark
Prior art keywords
kinase inhibitors
rip2 kinase
macrocyclic
macrocyclic rip2
inhibitors
Prior art date
Application number
DK15766800.5T
Other languages
English (en)
Inventor
Jan Hoflack
Petra Blom
Pascal Benderitter
Original Assignee
Oncodesign Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncodesign Sa filed Critical Oncodesign Sa
Application granted granted Critical
Publication of DK3194407T3 publication Critical patent/DK3194407T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/529Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim forming part of bridged ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK15766800.5T 2014-09-17 2015-09-17 Makrocykliske RIP2-kinaseinhibitorer DK3194407T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14185130 2014-09-17
PCT/EP2015/071347 WO2016042087A1 (en) 2014-09-17 2015-09-17 Macrocyclic rip2 kinase inhibitors

Publications (1)

Publication Number Publication Date
DK3194407T3 true DK3194407T3 (da) 2020-01-27

Family

ID=51687776

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15766800.5T DK3194407T3 (da) 2014-09-17 2015-09-17 Makrocykliske RIP2-kinaseinhibitorer

Country Status (26)

Country Link
US (1) US10676486B2 (da)
EP (1) EP3194407B1 (da)
JP (1) JP6736545B2 (da)
KR (1) KR102563829B1 (da)
CN (1) CN106687464B (da)
AU (1) AU2015316799B2 (da)
BR (1) BR112017004035B1 (da)
CA (1) CA2958782C (da)
DK (1) DK3194407T3 (da)
EA (1) EA032872B1 (da)
ES (1) ES2763344T3 (da)
HR (1) HRP20192334T1 (da)
HU (1) HUE048518T2 (da)
IL (1) IL250544B (da)
LT (1) LT3194407T (da)
MX (1) MX2017003469A (da)
MY (1) MY186523A (da)
PL (1) PL3194407T3 (da)
PT (1) PT3194407T (da)
SA (1) SA517381087B1 (da)
SG (1) SG11201701116XA (da)
SI (1) SI3194407T1 (da)
TW (1) TWI709563B (da)
UA (1) UA121315C2 (da)
WO (1) WO2016042087A1 (da)
ZA (1) ZA201701331B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180088113A (ko) * 2017-01-26 2018-08-03 한미약품 주식회사 이미다조피리다진 화합물
CN115698020A (zh) * 2020-01-31 2023-02-03 昂科迪塞恩精密医药公司(Opm) 大环rip2-激酶抑制剂
CN117659043A (zh) * 2022-09-07 2024-03-08 苏州朗睿生物医药有限公司 一种大环咪唑并[1,2-b]哒嗪衍生物及其制备方法和用途
WO2024146541A1 (en) * 2023-01-03 2024-07-11 Guangdong Newopp Biopharmaceuticals Co., Ltd. Macrocyclic compounds as usp1 inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS2334B (is) 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
DE69429357T2 (de) 1993-10-01 2002-08-14 Astrazeneca Ab, Soedertaelje Verfahren i
US6043358A (en) 1995-11-01 2000-03-28 Merck & Co., Inc. Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
WO2008058126A2 (en) * 2006-11-06 2008-05-15 Supergen, Inc. Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
AR077468A1 (es) * 2009-07-09 2011-08-31 Array Biopharma Inc Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
KR101852169B1 (ko) * 2010-05-20 2018-04-26 어레이 바이오파마 인크. Trk 키나제 저해제로서의 매크로시클릭 화합물
WO2013001310A1 (en) * 2011-06-30 2013-01-03 Centro Nacional De Investigaciones Oncológicas (Cnio) Macrocyclic compounds and their use as cdk8 inhibitors
TWI547494B (zh) * 2011-08-18 2016-09-01 葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之胺基喹唑啉類
MX342177B (es) 2011-09-30 2016-09-20 Ipsen Pharma Sas Inhibidores de cinasa 2 de repeticion rica en leucina (lrrk2) macrociclica.
CN103930427B (zh) * 2011-09-30 2016-03-09 昂科迪塞恩股份有限公司 大环flt3激酶抑制剂

Also Published As

Publication number Publication date
MY186523A (en) 2021-07-24
ZA201701331B (en) 2020-07-29
SI3194407T1 (sl) 2020-03-31
IL250544A0 (en) 2017-03-30
CA2958782C (en) 2024-01-09
EP3194407B1 (en) 2019-10-23
JP2017528481A (ja) 2017-09-28
BR112017004035A2 (pt) 2017-12-05
BR112017004035A8 (pt) 2023-05-09
SG11201701116XA (en) 2017-03-30
US10676486B2 (en) 2020-06-09
PL3194407T3 (pl) 2020-04-30
BR112017004035B1 (pt) 2023-11-14
TW201619168A (zh) 2016-06-01
KR20170048596A (ko) 2017-05-08
EA201790609A1 (ru) 2017-07-31
IL250544B (en) 2020-06-30
WO2016042087A1 (en) 2016-03-24
EP3194407A1 (en) 2017-07-26
KR102563829B1 (ko) 2023-08-03
CN106687464B (zh) 2020-03-03
JP6736545B2 (ja) 2020-08-05
AU2015316799A1 (en) 2017-04-27
HUE048518T2 (hu) 2020-07-28
LT3194407T (lt) 2020-01-27
ES2763344T3 (es) 2020-05-28
MX2017003469A (es) 2017-05-08
NZ730758A (en) 2023-09-29
SA517381087B1 (ar) 2021-02-09
PT3194407T (pt) 2020-01-20
TWI709563B (zh) 2020-11-11
AU2015316799B2 (en) 2019-07-11
HRP20192334T1 (hr) 2020-03-20
US20190127390A1 (en) 2019-05-02
CN106687464A (zh) 2017-05-17
EA032872B1 (ru) 2019-07-31
UA121315C2 (uk) 2020-05-12
CA2958782A1 (en) 2016-03-24

Similar Documents

Publication Publication Date Title
CL2016002502A1 (es) Inhibidores de biaril cinasa
DK3442972T3 (da) Bromdomænehæmmere
PL3218378T3 (pl) Pochodne 6-amino-7-bicyklo-7-deazapuryny jako inhibitory kinaz białkowych
DK3119772T3 (da) Heteroaryl syk-hæmmere
BR112017000042A2 (pt) inibidores de desmetilase-1 lisina-específica
DK3191487T3 (da) Spirocykliske cathepsin-c-inhibitorer
DK3125898T3 (da) Farmakofor til trail-induktion
DK3102778T3 (da) Fræseindretning
DK3186242T3 (da) Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere
DK3114120T3 (da) Tetrazolon-substituerede dihydropyridinon-mgat2-hæmmere
DK3341379T3 (da) EZH2-hæmmere
DK3231803T3 (da) Dihydroindolizinonderivat
DK3131898T3 (da) Fluoroalkylfluorenderivativer
DK3191466T3 (da) Azetidinyloxyphenylpyrrolidinforbindelser
DE112014006148A5 (de) Schubladenausziehführung
ZA201701331B (en) Macrocyclic rip2 kinase inhibitors
DE112015003475A5 (de) Spannfutter
MA44607A (fr) Inhibiteurs de kinase
DE112015002884A5 (de) Schublade
DK3481826T3 (da) Tyrosinkinaseinhibitorer
DK3436047T3 (da) Duale Ace-C-Domain-inhibitorer
BR112016027901A2 (pt) Compostos
FR3024538B1 (fr) Extensometre radial
FI20145287A (fi) Kaappisänky
TH1501006103A (th) สารยับยั้งโปรตีนไคเนส